177 related articles for article (PubMed ID: 24267245)
1. Oxidized LDL and AGE-LDL in circulating immune complexes strongly predict progression of carotid artery IMT in type 1 diabetes.
Hunt KJ; Baker N; Cleary P; Backlund JY; Lyons T; Jenkins A; Virella G; Lopes-Virella MF;
Atherosclerosis; 2013 Dec; 231(2):315-22. PubMed ID: 24267245
[TBL] [Abstract][Full Text] [Related]
2. Levels of oxidized LDL and advanced glycation end products-modified LDL in circulating immune complexes are strongly associated with increased levels of carotid intima-media thickness and its progression in type 1 diabetes.
Lopes-Virella MF; Hunt KJ; Baker NL; Lachin J; Nathan DM; Virella G;
Diabetes; 2011 Feb; 60(2):582-9. PubMed ID: 20980456
[TBL] [Abstract][Full Text] [Related]
3. Immune complexes containing modified lipoproteins are related to the progression of internal carotid intima-media thickness in patients with type 1 diabetes.
Lopes-Virella MF; McHenry MB; Lipsitz S; Yim E; Wilson PF; Lackland DT; Lyons T; Jenkins AJ; Virella G;
Atherosclerosis; 2007 Feb; 190(2):359-69. PubMed ID: 16530770
[TBL] [Abstract][Full Text] [Related]
4. High levels of oxidized LDL in circulating immune complexes are associated with increased odds of developing abnormal albuminuria in Type 1 diabetes.
Lopes-Virella MF; Carter RE; Baker NL; Lachin J; Virella G;
Nephrol Dial Transplant; 2012 Apr; 27(4):1416-23. PubMed ID: 21856760
[TBL] [Abstract][Full Text] [Related]
5. High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetes.
Lopes-Virella MF; Baker NL; Hunt KJ; Lyons TJ; Jenkins AJ; Virella G;
Diabetes Care; 2012 Jun; 35(6):1333-40. PubMed ID: 22511260
[TBL] [Abstract][Full Text] [Related]
6. Effect of intensive diabetes treatment on carotid artery wall thickness in the epidemiology of diabetes interventions and complications. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.
Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
Diabetes; 1999 Feb; 48(2):383-90. PubMed ID: 10334318
[TBL] [Abstract][Full Text] [Related]
7. High levels of AGE-LDL, and of IgG antibodies reacting with MDA-lysine epitopes expressed by oxLDL and MDA-LDL in circulating immune complexes predict macroalbuminuria in patients with type 2 diabetes.
Lopes-Virella MF; Hunt KJ; Baker NL; Virella G;
J Diabetes Complications; 2016; 30(4):693-9. PubMed ID: 26861948
[TBL] [Abstract][Full Text] [Related]
8. Progression of carotid artery intima-media thickness during 12 years in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study.
Polak JF; Backlund JY; Cleary PA; Harrington AP; O'Leary DH; Lachin JM; Nathan DM;
Diabetes; 2011 Feb; 60(2):607-13. PubMed ID: 21270271
[TBL] [Abstract][Full Text] [Related]
9. Oxidized LDL immune complexes and coronary artery calcification in type 1 diabetes.
Lopes-Virella MF; Baker NL; Hunt KJ; Lachin J; Nathan D; Virella G;
Atherosclerosis; 2011 Feb; 214(2):462-7. PubMed ID: 21156319
[TBL] [Abstract][Full Text] [Related]
10. Higher circulating levels of OxLDL % of LDL are associated with subclinical atherosclerosis in female patients with systemic lupus erythematosus.
Ahmad HM; Sarhan EM; Komber U
Rheumatol Int; 2014 May; 34(5):617-23. PubMed ID: 24101173
[TBL] [Abstract][Full Text] [Related]
11. Role of asymmetric dimethylarginine in the progression of carotid atherosclerosis in renal transplant patients.
Cobanoglu AK; Gungor O; Kircelli F; Altunel E; Asci G; Ozbek SS; Toz H; Ok E
Int Urol Nephrol; 2013 Oct; 45(5):1463-9. PubMed ID: 23212148
[TBL] [Abstract][Full Text] [Related]
12. [Oxidized LDL and C-reactive protein level in relation to carotid intima-media thickness in population with risk factors for atherosclerosis].
Caparević Z; Kostić N; Ilić S; Radojković J; Marina Dj; Pencić B; Radojković I
Srp Arh Celok Lek; 2009; 137(3-4):140-5. PubMed ID: 19459559
[TBL] [Abstract][Full Text] [Related]
13. The levels of MDA-LDL in circulating immune complexes predict myocardial infarction in the VADT study.
Lopes-Virella MF; Hunt KJ; Baker NL; Virella G; Moritz T;
Atherosclerosis; 2012 Oct; 224(2):526-31. PubMed ID: 22963984
[TBL] [Abstract][Full Text] [Related]
14. Nuclear magnetic resonance-determined lipoprotein subclass profile in the DCCT/EDIC cohort: associations with carotid intima-media thickness.
Lyons TJ; Jenkins AJ; Zheng D; Klein RL; Otvos JD; Yu Y; Lackland DT; McGee D; McHenry MB; Lopes-Virella M; Garvey WT;
Diabet Med; 2006 Sep; 23(9):955-66. PubMed ID: 16922701
[TBL] [Abstract][Full Text] [Related]
15. Immune Complexes and the Risk of CVD in Type 1 Diabetes.
Lopes-Virella MF; Bebu I; Hunt KJ; Virella G; Baker NL; Braffett B; Gao X; Lachin JM;
Diabetes; 2019 Sep; 68(9):1853-1860. PubMed ID: 31217176
[TBL] [Abstract][Full Text] [Related]
16. Plasma total homocysteine and carotid intima-media thickness in type 1 diabetes: a prospective study.
Basu A; Jenkins AJ; Stoner JA; Thorpe SR; Klein RL; Lopes-Virella MF; Garvey WT; Lyons TJ;
Atherosclerosis; 2014 Sep; 236(1):188-195. PubMed ID: 25063949
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus.
Lopes-Virella MF; Virella G; Orchard TJ; Koskinen S; Evans RW; Becker DJ; Forrest KY
Clin Immunol; 1999 Feb; 90(2):165-72. PubMed ID: 10080827
[TBL] [Abstract][Full Text] [Related]
18. Nuclear magnetic resonance-determined lipoprotein subclasses and carotid intima-media thickness in type 1 diabetes.
Basu A; Jenkins AJ; Zhang Y; Stoner JA; Klein RL; Lopes-Virella MF; Garvey WT; Lyons TJ;
Atherosclerosis; 2016 Jan; 244():93-100. PubMed ID: 26600440
[TBL] [Abstract][Full Text] [Related]
19. LDL-containing immune complexes in the DCCT/EDIC cohort: associations with lipoprotein subclasses.
Klein RL; Carter RE; Jenkins AJ; Lyons TJ; Baker NL; Gilbert GE; Virella G; Lopes-Virella MF;
J Diabetes Complications; 2011; 25(2):73-82. PubMed ID: 20605479
[TBL] [Abstract][Full Text] [Related]
20. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus.
Nathan DM; Lachin J; Cleary P; Orchard T; Brillon DJ; Backlund JY; O'Leary DH; Genuth S; ;
N Engl J Med; 2003 Jun; 348(23):2294-303. PubMed ID: 12788993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
